increas
number
outbreak
lpai
hpai
virus
poultri
major
public
anim
health
implic
continu
rapid
evolut
subtyp
emerg
new
variant
influenc
abil
undertak
effect
surveil
retrovir
pseudotyp
bear
influenza
haemagglutinin
ha
neuraminidas
na
envelop
glycoprotein
repres
flexibl
platform
sensit
readili
standard
influenza
serolog
assay
describ
multiplex
assay
studi
neutral
antibodi
direct
influenza
ha
assay
permit
measur
neutral
antibodi
respons
two
antigen
distinct
serumplasma
sampl
thu
increas
amount
qualiti
serolog
data
acquir
valuabl
sera
sera
obtain
chicken
vaccin
monoval
vaccin
chicken
vaccin
bival
vaccin
turkey
natur
infect
viru
evalu
assay
result
correl
strongli
data
obtain
hi
assay
show
pseudotyp
highli
stabl
basic
coldchain
storag
condit
follow
multipl
round
freezethaw
propos
robust
assay
may
practic
util
infield
serosurveil
vaccin
studi
resourcelimit
region
worldwid
increas
number
outbreak
low
pathogen
avian
influenza
lpai
high
pathogen
avian
influenza
hpai
virus
poultri
major
public
anim
health
implic
signific
econom
impact
evalu
evid
influenza
infect
vaccin
effici
poultri
speci
assess
via
measur
immunolog
respons
avian
influenza
virus
serolog
assay
repres
import
tool
serosurveil
studi
particularli
new
outbreak
locat
although
vaccin
combin
improv
biosecur
success
prevent
signific
mortal
product
loss
ongo
evolut
viru
requir
develop
surveil
system
ensur
vaccin
continu
effect
influenza
virus
infect
poultri
divid
two
group
hpai
lpai
basi
abil
caus
diseas
differ
human
anim
health
implic
evid
support
hypothesi
hpai
virus
aris
result
mutat
viru
introduc
wild
bird
poultri
thu
believ
lpai
virus
progenitor
highli
pathogen
variant
recogn
import
control
hpai
virus
also
lpai
strain
domest
poultri
despit
current
knowledg
mechan
mutat
lpai
hpai
insuffici
predict
influenza
strain
mutat
hpai
variant
despit
signific
effort
put
develop
avian
vaccin
serolog
surveil
repres
one
major
tool
evalu
immun
state
avian
popul
especi
abil
certain
subtyp
journal
immunolog
research
mutat
antigen
drift
mechan
due
longterm
circul
among
vaccin
popul
serolog
repres
power
sensit
approach
detect
presenc
avian
influenza
antibodi
popul
occurr
antigen
drift
shift
must
taken
consider
render
subtypespecif
serolog
test
hi
neutral
assay
less
sensit
new
emerg
strain
influenza
addit
serolog
crossreact
antigen
distinct
influenza
virus
occur
consequ
preced
vaccin
exposur
result
complic
interpret
serolog
find
address
issu
new
assay
warrant
summar
within
appendix
consult
summari
may
faooiewho
joint
technic
consult
avian
influenza
humananim
interfac
octob
verona
itali
make
recommend
develop
valid
sensit
specif
test
detect
antibodi
avian
influenza
virus
avian
nonavian
speci
includ
human
substitut
rate
significantli
higher
influenza
ha
na
gene
compar
intern
gene
retrovir
lentivir
pseudotyp
bear
ha
na
envelop
glycoprotein
devolv
rest
viru
ideal
tool
monitor
effect
viral
evolut
serolog
outcom
previous
shown
use
sensit
lowcontain
assay
measur
antibodi
respons
hpai
lpai
influenza
strain
potenti
differ
influenza
subtyp
upon
avail
novel
viral
rnacdna
hana
gene
sequenc
readili
clone
custom
synthes
pseudotyp
lentivir
vector
prepar
use
neutral
assay
therefor
assay
continu
updat
measur
efficaci
current
vaccin
therapeut
well
serosurveil
also
use
lentivir
pseudotyp
shown
addit
advantag
compar
serolog
assay
sinc
system
potenti
adapt
multiplex
format
benefici
repercuss
larg
scale
serolog
investig
need
undertaken
studi
flexibl
influenza
pseudotyp
system
exploit
develop
multiplex
assay
studi
neutral
antibodi
respons
direct
belong
influenza
group
hpai
clade
hpai
clade
group
hpai
incorpor
differ
luciferas
renilla
firefli
report
gene
lentivir
genom
two
separ
pseudotyp
bear
antigen
distinct
envelop
glycoprotein
surfac
presenc
neutralis
antibodi
two
influenza
evalu
within
singl
serum
sampl
singl
assay
plate
well
initi
sera
chicken
vaccin
monoval
vaccin
turkey
natur
infect
influenza
outbreak
test
pseudotyp
neutral
assay
ppnt
assay
use
monoplex
format
serolog
result
compar
standard
refer
hi
test
subsequ
influenza
pseudotyp
use
screen
panel
sera
collect
chicken
vaccin
bival
vaccin
use
multiplex
format
subtypespecif
antibodi
respons
serum
sampl
direct
pseudotyp
evalu
exploit
use
two
differ
report
offer
new
assay
format
infield
serosurveil
vaccin
studi
also
shown
pseudotyp
highli
stabl
basic
coldchain
storag
condit
c
c
multipl
round
freezethaw
make
assay
potenti
applic
use
infield
endem
area
describ
recent
rabi
lyssavirus
avian
sera
provid
fao
oie
nation
refer
laboratori
newcastl
diseas
avian
influenza
istituto
zooprofilattico
sperimental
dell
venezi
consist
ten
sera
posit
collect
chicken
vaccin
inactiv
vaccin
ten
sera
posit
collect
turkey
italian
outbreak
caus
lpai
viru
ten
sera
posit
collect
chicken
vaccin
inactiv
bival
vaccin
produc
lpai
strain
forti
neg
sera
includ
studi
obtain
chicken
test
ai
antibodyfre
enzymelink
immunosorb
assay
elisa
agaros
gel
immunodiffus
agid
assay
use
standard
protocol
describ
previous
addit
two
hyperimmun
sheep
sera
rais
ha
rais
ha
kindli
provid
nibsc
except
neuraminidas
activ
provid
cognat
na
plasmid
lieu
exogen
bacteri
na
addit
parallel
use
transfect
protocol
batch
hek
produc
cell
hpai
pseudotyp
carri
renilla
luciferas
gene
pcrlfw
gener
use
firefli
luciferas
marker
infect
hek
target
cell
titrat
influenza
pseudotyp
carri
order
calcul
input
viru
dose
requir
proceed
pseudotypebas
neutral
assay
titr
influenza
pseudotyp
quantifi
luminesc
express
express
rel
luminesc
unit
rlu
measur
luminomet
glomax
promega
two
control
requir
titrat
neg
control
cell
glycoprotein
control
ha
na
addit
stabil
studi
pcslzw
express
lacz
gene
use
conjunct
clade
ha
exogen
bacteri
na
unitml
sigma
uk
produc
lacz
pseudotyp
virus
infect
hek
cell
detect
use
xgal
substrat
describ
us
previous
lentivir
pseudotyp
bear
rabi
envelop
glycoprotein
util
comparison
serum
sampl
l
twofold
serial
dilut
cultur
medium
dmem
glutamax
supplement
fb
penicillinstreptomycin
mix
pseudotyp
viru
rlu
luciferas
input
vv
ratio
incub
c
hour
hek
cell
ad
well
white
flatbottom
tissu
cultur
plate
hour
later
pseudotyp
transduct
titr
obtain
rang
dilut
point
express
rluml
arithmet
mean
calcul
serum
sampl
rlu
normal
compar
signal
detect
absenc
pseudotyp
viru
equival
neutral
signal
neg
control
equival
neutral
inhibitori
dose
ic
determin
reciproc
serum
dilut
result
reduct
singl
round
infect
report
gene
mediat
signal
allow
detect
neutral
antibodi
respons
two
differ
influenza
virus
well
flatbottom
tissu
cultur
plate
fix
amount
correspond
rlu
estim
prior
pseudotyp
titrat
influenza
pseudotyp
one
contain
firefli
report
gene
renilla
report
gene
ad
well
twofold
serial
dilut
serum
sampl
l
dispens
togeth
cell
cultur
medium
dmem
glutamax
supplement
fb
penicillinstreptomycin
hour
neutral
antibodi
respons
subtyp
detect
use
dualglo
reagent
promega
differenti
two
report
gene
detail
manufactur
instruct
neutral
antibodi
titr
influenza
pseudotyp
could
record
serum
sampl
concurr
analysi
data
analys
undertaken
use
excel
graphpad
prism
version
antibodi
titr
observ
influenza
pseudotyp
use
monoplex
multiplex
assay
express
geometr
mean
titer
gmt
firstli
ic
valu
calcul
describ
serum
dilut
result
neutral
activ
reduct
serum
sampl
test
duplic
transform
logarithm
scale
subsequ
geometr
mean
duplic
observ
calcul
statist
analys
data
correl
coeffici
pearson
correl
analysi
perform
use
graphpad
prism
radial
tree
ha
amino
acid
ident
grid
construct
matlab
mathwork
construct
pseudotyp
aviet
ha
na
ha
na
ha
na
encod
firefli
luciferas
report
gene
addit
use
multiplex
assay
pseudotyp
achicken
ha
na
encod
renilla
luciferas
report
phylogenet
relationship
pseudotyp
serolog
antigen
antigen
util
studi
visual
radial
tree
figur
use
firefli
luciferas
marker
infect
hek
cell
shown
high
titr
function
pseudotyp
bear
three
differ
envelop
glycoprotein
pair
success
produc
data
shown
base
viru
titr
decid
use
rlu
input
viru
dose
subsequ
neutral
assay
pseudotyp
requir
reliabl
coldchain
storag
laboratori
undertak
ai
serolog
vari
greatli
especi
resourc
limit
region
world
therefor
pseudotypebas
assay
adopt
region
futur
assum
primarili
cost
reason
lacz
report
gene
choic
laboratori
may
frequent
disrupt
ideal
pseudotyp
storag
condit
c
simpli
may
access
c
freezer
therefor
undertook
seri
aviet
ha
pseudotyp
viru
stabil
investig
storag
viru
higher
temperatur
c
standard
freezer
c
standard
fridg
room
temperatur
subject
pseudotyp
viru
multipl
freezethaw
cycl
initi
titr
lacz
pseudotyp
ifuml
infect
remain
five
cycl
freezethaw
figur
parallel
pseudotyp
bear
rabi
envelop
glycoprotein
subject
freezethaw
regimen
found
lose
approxim
activ
respect
per
freezethaw
cycl
figur
relat
temperatur
storag
variat
effect
pseudotyp
viabil
figur
show
aviet
ha
pseudotyp
store
c
maintain
infect
compar
storag
c
least
month
make
assay
readili
applic
vast
major
laboratori
cycl
freezethaw
percentag
initi
viru
titr
remain
figur
influenc
freezethaw
cycl
pseudotyp
viru
titr
stabil
lacz
pseudotyp
evalu
subject
aliquot
viru
cycl
freezethaw
result
pseudotyp
bear
rabi
viru
envelop
protein
shown
comparison
one
biolog
replic
pseudotyp
viru
use
gener
three
technic
replic
error
bar
repres
standard
deviat
worldwid
also
shown
figur
virus
could
addit
store
c
week
reduct
infect
room
temperatur
c
week
reduct
infect
pseudotyp
three
panel
sera
posit
posit
neg
serum
sampl
initi
test
use
monoplex
pseudotypebas
format
initi
pilot
studi
carri
hyperimmun
sheep
sera
test
abil
neutral
influenza
pseudotyp
bear
stabil
lacz
pseudotyp
evalu
store
aliquot
viru
differ
temperatur
month
pseudotyp
titr
time
cours
given
rel
titr
viru
stock
maintain
c
consid
optim
storag
temperatur
retrovir
pseudotyp
one
biolog
replic
pseudotyp
viru
use
gener
three
technic
replic
error
bar
repres
standard
deviat
influenza
pseudotyp
neutral
sera
inhibit
pseudotyp
entri
serum
dilut
sera
whilst
pseudotyp
neutral
inhibit
dilut
lack
crossneutr
antibodi
respons
subtyp
consist
differ
cluster
within
group
group
hasubtyp
base
phylogenet
relationship
analysi
influenza
subtyp
accord
analysi
ha
belong
group
cluster
togeth
ha
belong
group
cluster
journal
immunolog
research
figur
amino
acid
ident
grid
pseudotyp
hi
vaccin
antigen
strain
mv
monoval
vaccin
antigen
bv
bival
vaccin
antigen
pp
pseudotyp
antigen
hi
haemagglutin
inhibit
assay
antigen
togeth
subsequ
panel
ten
sera
collect
chicken
vaccin
monoval
inactiv
vaccin
produc
strain
run
order
comprehens
evalu
util
assay
avian
serolog
set
test
use
pseudotyp
particl
serolog
profil
obtain
ppnt
assay
also
compar
obtain
hi
test
ten
sera
posit
hi
test
use
refer
antigen
titr
rang
also
confirm
posit
ppnt
assay
use
gmt
rang
gmt
rang
tabl
panel
test
hpai
pseudotyp
six
ten
sera
also
found
posit
gmt
rang
tabl
shown
figur
titr
obtain
via
hi
correl
strongli
titr
obtain
use
hpai
pseudotyp
belong
two
differ
clade
clade
avietnam
clade
despit
fact
use
two
serolog
assay
optim
match
percentag
amino
acid
ident
pseudotyp
antigen
hi
antigen
vaccin
antigen
shown
figur
also
observ
figur
b
ten
sera
neutral
hpai
pseudotyp
virus
differ
magnitud
found
absolut
titer
express
mean
sd
significantli
lower
obtain
panel
test
confirm
valu
analyz
use
student
test
pair
data
set
figur
next
panel
ten
sera
obtain
turkey
natur
infect
strain
titr
rang
low
high
test
hi
hi
refer
antigen
subsequ
test
use
pseudotyp
ten
sera
found
posit
test
pseudotyp
gmt
rang
one
serum
sampl
posit
gmt
avietnam
tabl
previous
shown
panel
posit
sera
compar
serolog
approach
undertaken
order
assess
whether
result
obtain
pseudotyp
neutral
assay
reflect
obtain
hi
test
use
regress
analysi
pair
dataset
gener
sampl
compris
also
neg
sera
pearson
correl
test
result
analysi
reveal
highli
statist
signific
correl
antibodi
titer
obtain
assay
correl
coeffici
ppnt
hi
panel
posit
figur
lpai
lpai
monoplex
describ
multiplex
use
fireflyrenilla
ppnt
assay
undertaken
pseudotyp
shown
tabl
sera
confirm
posit
test
monoplex
assay
titr
express
gmt
rang
one
serum
sampl
n
posit
hi
found
neg
ppnt
gmt
neutral
antibodi
respons
also
found
posit
sera
gmt
rang
show
seen
panel
posit
sera
tabl
overal
higher
gmt
compar
pseudotyp
belong
clade
also
pseudotyp
gmt
mirror
obtain
pseudotyp
gmt
one
serum
sampl
n
neg
gmt
two
sera
propos
posit
threshold
subsequ
neutral
antibodi
titr
obtain
standard
dual
assay
undertaken
gmt
report
tabl
reveal
strong
correl
result
standard
dual
ppnt
assay
pearson
correl
figur
neutral
antibodi
titr
obtain
monoplex
assay
use
carri
firefli
luciferas
gene
mirror
obtain
panel
sera
test
firefli
gene
mix
carri
renilla
gene
similar
result
observ
antibodi
respons
test
monoplex
multiplex
assay
figur
magnitud
neutral
antibodi
respons
observ
ppnt
assay
reflect
obtain
standard
hi
test
although
hi
test
perform
evalu
hamedi
antibodi
respons
versu
influenza
antigen
tabl
sinc
outbreak
domest
poultri
increas
frequenc
like
due
complex
set
factor
improv
diagnost
tool
climat
fluctuat
chang
trade
flow
poultri
product
one
logic
step
understand
limit
possibl
spread
avian
influenza
virus
human
control
circul
amongst
avian
speci
monitor
ai
viru
exposur
poultri
initi
via
identif
activ
infect
howev
due
abil
influenza
virus
circumv
immun
acquir
infect
vaccin
progress
antigen
drift
serolog
surveil
avian
sampl
also
particularli
import
serolog
techniqu
play
key
role
variou
aspect
influenza
surveil
vaccin
develop
evalu
use
assess
presenc
antibodi
past
infect
respons
circul
influenza
strain
vaccin
compon
veterinari
point
view
serolog
virolog
surveil
necessari
monitor
system
ai
virus
circul
among
poultri
speci
also
prevent
control
tool
strain
possibl
pandem
potenti
recent
studi
provid
impetu
futur
avian
serolog
rather
move
toward
singl
assay
approach
implement
strategi
involv
convent
novel
technolog
use
conjunct
valid
standard
test
compar
serolog
aim
achiev
holist
view
serolog
respons
newer
assay
like
pseudotypebas
neutral
assay
present
studi
key
shown
previous
retrovir
pseudotyp
mlv
base
aviet
use
measur
antibodi
respons
chicken
immun
avian
virus
current
studi
lentivir
pseudotyp
employ
form
basi
develop
multiplex
report
firefli
luciferas
renilla
luciferas
neutral
assay
subtyp
virus
pseudotyp
system
allow
measur
neutral
antibodi
respons
two
antigen
distinct
ai
ha
envelop
glycoprotein
avian
serum
sampl
individu
compon
employ
construct
pseudotyp
use
multiplex
assay
chosen
set
interchang
plasmid
avail
assay
develop
retrovir
lentivir
plasmid
code
gagpol
core
structur
protein
ha
na
express
plasmid
retrovir
vector
incorpor
report
gene
firefli
renilla
luciferas
employ
studi
potenti
wide
rang
report
gene
use
assay
green
fluoresc
protein
gfp
red
rfp
yellow
yfp
secret
embryon
alkalin
phosphatas
seap
lacz
order
pseudotyp
assay
wide
applic
deploy
potenti
within
differ
laboratori
worldwid
avail
differ
report
system
highli
desir
hivbas
gfp
report
plasmid
pcsgw
describ
previous
context
pseudotypebas
neutral
assay
modifi
pcr
subclon
express
altern
report
gene
firefli
luciferas
pcsflw
renilla
luciferas
pcsrlw
lacz
pcslzw
three
type
luciferas
report
base
assay
sensit
reproduc
also
simplest
use
term
handson
time
downstream
data
analysi
reason
chosen
serolog
assay
describ
current
studi
howev
due
rel
high
cost
necessari
reagent
luciferas
assay
necess
special
equip
luminomet
luciferas
assay
may
limit
applic
laboratori
resourc
poor
region
gfp
base
assay
requir
supplementari
reagent
necessit
special
equip
fluoresc
microscop
plate
flow
cytometri
facil
cost
basic
fluoresc
microscop
howev
make
technolog
applic
middl
lowresourc
lab
deploy
lacz
base
assay
cost
effect
necessari
reagent
cheapli
avail
special
equip
unnecessari
make
ideal
deploy
resourc
poor
area
serosurveil
domest
poultri
like
carri
addit
fireflyrenilla
use
studi
technic
feasibl
multiplex
pair
pseudotyp
virus
carri
gfprfp
laczseap
combin
lowresourc
laboratori
use
lacz
thu
chosen
report
gene
choic
infield
applic
studi
involv
freezethaw
store
pseudotyp
virus
outsid
c
facil
use
recent
similar
studi
lyssaviru
pseudotyp
result
show
highli
suitabl
use
stabl
time
differ
storag
temperatur
subject
multipl
cycl
freezethaw
interestingli
pseudotyp
viru
bear
hiv
envelop
glycoprotein
significantli
sensit
freezethaw
procedur
virus
bear
influenza
rabi
viru
glycoprotein
like
due
fact
hiv
glycoprotein
rel
unstabl
frozen
addit
multiplex
assay
use
dual
report
gene
system
interassay
variabl
like
reduc
sinc
singl
serum
dilut
seri
need
perform
prepar
target
cell
use
two
virus
antibodi
respons
subtyp
viru
may
serv
intern
serocontrol
antibodi
respons
subtyp
vice
versa
two
separ
luciferas
report
employ
result
collect
ppnt
assay
statist
signific
perform
monoplex
multiplex
influenza
strain
result
monoplex
mirror
obtain
multiplex
assay
figur
system
could
subsequ
refin
possibl
increas
multiplex
capabl
use
report
system
detect
luminesc
fluoresc
signal
eg
gfprfp
fireflyrenilla
luciferas
could
readili
adapt
highthroughput
larg
serum
panel
use
also
benefici
econom
implic
use
assay
sinc
antibodi
respons
two
virus
requir
highcontain
facil
rel
fewer
reagent
hi
mn
test
ppnt
assay
describ
serum
spare
antigen
spare
l
especi
certain
hpai
strain
less
l
correspond
pseudotyp
input
rlu
pseudotyp
per
plate
requir
possibl
multiplex
ppnt
assay
measur
neutral
antibodi
respons
larg
panel
influenza
virus
drift
variant
faster
accur
labori
wildtyp
viru
microneutr
thu
provid
comprehens
data
antigen
evolut
avian
influenza
virus
moreov
major
limit
use
hi
assay
practic
gener
influenza
screen
signific
level
intralaboratori
variabl
demonstr
human
serolog
requir
greater
amount
sera
occurr
crossreact
subtyp
need
taken
account
contrari
pseudotyp
particl
shown
particularli
sensit
potenti
detect
antibodi
respons
variat
within
influenza
subclad
also
show
static
signific
correl
compar
hi
test
tabl
figur
recent
studi
rais
possibl
lower
incorpor
ha
spike
lentivir
pseudotyp
compar
wild
viru
make
pseudotyp
sensit
allow
bind
antibodi
antigen
site
ha
head
also
ha
stalk
base
data
obtain
studi
futur
refin
assay
warrant
contribut
toward
recommend
develop
new
assay
outlin
faooiewho
joint
technic
consult
document
addit
studi
provid
basi
futur
composit
studi
collabor
laboratori
involv
determin
whether
level
intraand
interlaboratori
variabl
ppnt
assay
lower
found
hi
inde
mn
enabl
ppnt
assay
becom
accept
larg
scale
test
context
avian
human
influenza
surveil
also
integr
surveil
neglect
influenza
strain
circul
hors
pig
seal
dog
eg
